Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

KAMRAB 150 UNIT

RABIES IMMUNOGLOBULIN (HUMAN) : 150 UNIT · DIN 02482436 · KAMADA LTD

Health Canada status: MARKETED

What is KAMRAB?

KAMRAB 150 UNIT contains RABIES IMMUNOGLOBULIN (HUMAN) : 150 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02482436, held by KAMADA LTD, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 06-Apr-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is KAMRAB used for?

KamRAB is a human rabies immunoglobulin (HRIG) indicated for passive, transient post-exposure prophylaxis (PEP) of rabies infection, when given immediately after contact with a rabid or possibly rabid animal. KamRAB should be administered concurrently with a full course of rabies vaccine.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02482436
Brand nameKAMRAB
Generic / active ingredientRABIES IMMUNOGLOBULIN (HUMAN) : 150 UNIT
ManufacturerKAMADA LTD
Strength150 UNIT
Dosage formSOLUTION
Route of administrationINTRAMUSCULAR
ScheduleSchedule D
ATC codeJ06BB05 RABIES IMMUNOGLOBULIN
AHFS class80:04.00
BiosimilarNo
Health Canada statusMARKETED
Status date06-Apr-2020
Original market date2020-04-06 00:00:00

How is it stored and handled?

Store KamRAB at 2 - 8 °C (36 - 46 °F). Do not freeze. Keep vial in carton until use. KamRAB may be stored at room temperatures not exceeding 25 °C (77 °F) for up to one month. Use within one month after removal from refrigeration, Do not return to refrigeration.

How is it supplied?

2.0 mL vials and 10.0 mL vials

What can be used instead?

Other Canadian products sharing ATC code J06BB05 RABIES IMMUNOGLOBULIN. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
HYPERRAB300 UNITSOLUTIONGRIFOLS THERAPEUTICS LLCMARKETEDDIN 02486571
HYPERAB RABIES IMMUNE GLOBULIN HUMAN16.5 %LIQUIDCUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.CANCELLED POST MARKETDIN 00345733
HYPERRAB S/D150 UNITSOLUTIONGRIFOLS THERAPEUTICS LLCCANCELLED POST MARKETDIN 02230700
IMOGAM RABIES INJ 150UNIT/ML150 UNITLIQUIDPASTEUR MÉRIEUX SERUMS ET VACCINS, S.A.CANCELLED POST MARKETDIN 01910477
IMOGAM RABIES PASTEURIZED150 UNITSOLUTIONSANOFI PASTEUR LIMITEDCANCELLED POST MARKETDIN 02237328
KAMRAB150 UNITSOLUTIONKAMADA LTDAPPROVEDDIN 02482509

Who else supplies RABIES IMMUNOGLOBULIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. RABIES IMMUNOGLOBULIN appears in 4 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for KAMRAB

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02482436. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.